Cas:8025-81-8 Spiramycin powder
| product name |
Spiramycin |
| cas number |
8025-81-8 |
| apperance |
white powder |
| Density |
1.2±0.1 g/cm3 |
| MF |
C43H74N2O14 |
| MW |
843.053 |
Spiramycin, the English name is Spiramycin. This product is white or slightly yellow powder, slightly odorous; slightly hygroscopic; this product is soluble in methanol, ethanol, acetone or ether, almost insoluble in water, and insoluble in petroleum ether. It is a macrolide antibiotic obtained from the culture medium of Streptomyces ambofaciens. Spiramycin is the acetate of acetylspiramycin. After oral administration, the acetyl group is removed to show strong antibacterial effect. Spiramycin is a strong bacteriostatic agent, and it has a bactericidal effect only at very high concentrations. This product has a strong antibacterial effect and antibacterial post effect (PAE) in the body, can enhance the phagocytosis of phagocytes, and is widely distributed in the body. This product has a higher concentration in tissue cells than erythromycin and has less side effects than erythromycin. This product can be used to treat ear, nose, throat and respiratory tract infections caused by gram-positive bacteria and certain gram-negative bacteria. It is suitable for the treatment of otitis media, periodontitis, acute sinusitis and other oral cavity and ear nose throat caused by sensitive bacteria. Branch infection. It can also be used to treat toxoplasmosis.
1. It is suitable for the treatment of respiratory infections and skin and soft tissue infections caused by sensitive bacteria, including: pharyngitis, tonsillitis, bronchitis, pneumonia, pyoderma, erysipelas and scarlet fever, etc.
2. It is suitable for the treatment of otitis media, periodontitis, acute sinusitis and other oral and otolaryngology infections caused by sensitive bacteria.
3. It can also be used to treat toxoplasmosis.
Audited Supplier 
){kind=link}
){kind=link}